Drug discovery centers are working hard to maintain strong pipelines of novel therapeutic agents and reduce the high cost of failure in drug development. To help, Molecular Devices has developed a wide range of bioanalytical systems and software to support drug discovery research.
We strive to understand the unique needs of our customers working in drug discovery and have developed a strong portfolio of products focused on streamlining lab workflows, reducing costs, and minimizing the time needed to identify high-priority lead compounds.
From target evaluation to early safety assessments, our bioanalytical systems for high-throughput screening, high-content analysis, automated patch clamp, label-free analysis, and multi-mode microplate-based detection are ideal choices for reducing costs and strengthening therapeutic pipelines.
NEW ScanLater Western Blot Detection System - Enables western blot and ELISA detection on your microplate reader. Learn more.
Automation: Our instruments offer built-in automation or are compatible with solutions from automation partners.